跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VISIPAQUE iodixanol 32.6g/50mL (652mg/mL) injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
VISIPAQUE iodixanol 32.6g/50mL (652mg/mL) injection vial
Approved
STANDARD
VISIPAQUE iodixanol 32.6g/50mL (652mg/mL) injection vial
GE Healthcare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
ecb7b208a3abaac1
Company
GE Healthcare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
ecb7b208a3abaac1
Product Name
VISIPAQUE iodixanol 32.6g/50mL (652mg/mL) injection vial
Artg Id
49594
Artg Name
VISIPAQUE iodixanol 32.6g/50mL (652mg/mL) injection vial
Sponsor
GE Healthcare Australia Pty Ltd
Company Detail Path
/organization/ge-healthcare-australia-pty-limited
Artg Date
1995-06-27
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/8996125ee0e4e913b4b34a68b43d8642.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/ac8d1dc4da3e22fafe78e2386fb7fdc1.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
ecb7b208a3abaac1
Type
Standard
Back to TGA Approvals